Orca-T
A Single Center, Non-Randomized, Phase 1b Study of Orca-T Following Escalated Dose of Total Marrow and Lymphoid Irradiation in Patients With Acute Leukemias and MDS
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 33 patients (estimated)
- Sponsors
- City of Hope Medical Center
- Collaborators
- National Cancer Institute (NCI)
- Tags
- T Cell (Allogeneic)
- Trial Type
- Treatment
- Last Update
- 4 weeks ago
- SparkCures ID
- 1825
- NCT Identifier
- NCT06195891
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.